Medeon Biodesign Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	520.79	513.37	1,238	483.9	735.32
Short-Term Investments	656.96	652.18	862.1	1,025	1,608
Trading Asset Securities	42.12	41.66	41.93	37.87	6.48
Cash & Short-Term Investments	1,220	1,207	2,142	1,547	2,350
Cash Growth	1.05%	-43.64%	38.44%	-34.16%	7.49%
Accounts Receivable	39.26	37.84	41.77	32.35	10.12
Other Receivables	7.17	7.71	8.37	26.65	5.12
Receivables	46.43	45.55	50.15	59.01	15.25
Inventory	24.84	34.1	10.77	10.06	-
Prepaid Expenses	-	-	24.89	21.42	24.68
Other Current Assets	31.02	30.34	-	-	-
Total Current Assets	1,322	1,317	2,228	1,638	2,390
Property, Plant & Equipment	267.83	355.47	321.82	340.24	44.52
Long-Term Investments	-	-	-	1,876	1,847
Goodwill	106.74	106.74	106.74	106.74	39.23
Other Intangible Assets	45.36	55.01	64.33	73.44	39.71
Long-Term Deferred Tax Assets	32.95	32.95	-	-	-
Other Long-Term Assets	4.77	10.37	26.46	5.59	4.58
Total Assets	1,780	1,878	2,747	4,040	4,364
Accounts Payable	7.55	12	5.36	3.94	0.05
Accrued Expenses	85.37	113.03	98.01	73.09	68.33
Current Portion of Leases	41.39	54.56	47.15	36.69	14.53
Current Income Taxes Payable	-	-	37.97	56.78	66.74
Current Unearned Revenue	7.94	4.51	3.11	0.86	0.65
Other Current Liabilities	18.7	31.54	30.16	27.17	10
Total Current Liabilities	160.96	215.64	221.76	198.51	160.3
Long-Term Leases	71.66	113.84	139.59	162.22	15.71
Long-Term Deferred Tax Liabilities	10.41	12.36	14.31	15.74	-
Total Liabilities	243.03	341.84	375.65	376.48	176
Common Stock	969.45	922.45	922.45	878.4	732.34
Additional Paid-In Capital	-	-	1,341	1,344	1,349
Retained Earnings	-1,496	-792.94	31.25	1,355	2,072
Treasury Stock	-	-5.25	-10.6	-10.6	-10.6
Comprehensive Income & Other	2,002	1,396	36.18	30.94	-12.49
Total Common Equity	1,476	1,520	2,320	3,597	4,130
Minority Interest	61.03	15.71	51.51	66.1	58.15
Shareholders' Equity	1,537	1,536	2,371	3,664	4,188
Total Liabilities & Equity	1,780	1,878	2,747	4,040	4,364
Total Debt	113.05	168.4	186.74	198.91	30.24
Net Cash (Debt)	1,107	1,039	1,955	1,348	2,320
Net Cash Growth	6.55%	-46.87%	45.01%	-41.87%	36.98%
Net Cash Per Share	11.99	11.27	21.24	14.65	25.19
Filing Date Shares Outstanding	96.94	92.14	92.04	92.02	92.02
Total Common Shares Outstanding	96.94	92.14	92.04	92.02	92.02
Working Capital	1,161	1,102	2,006	1,439	2,230
Book Value Per Share	15.22	16.50	25.21	39.10	44.89
Tangible Book Value	1,324	1,358	2,149	3,417	4,051
Tangible Book Value Per Share	13.65	14.74	23.35	37.14	44.03
Machinery	220.85	229.55	178.49	168.97	46.34
Leasehold Improvements	100.5	84.96	46.22	45.6	6.43

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.